Charges for restructuring programs and asset related charges, which include asset impairments, were $384 million and $807 million for the three and nine months ended September 30, 2020 ($82 million and $290 million for the three and nine months ended September 30, 2019). These charges were recorded in "Restructuring and asset related charges - net" in the interim Consolidated Statements of Operations. The total liability related to restructuring programs was $127 million at September 30, 2020 ($162 million at December 31, 2019). Restructuring activity consists of the following:

In the first quarter of 2020, the Company approved restructuring actions designed to capture near-term cost reductions and to further simplify certain organizational structures in anticipation of the expected closure of the Intended N&B Transaction (the "2020 Restructuring Program").


	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
In millions	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
Severance and related benefit costs	$	10	$	112
Asset related charges	4		28
Total restructuring and asset related charges - net	$	14	$	140


2020 Restructuring Program Charges by Segment	Three Months Ended September 30, 2020		Nine Months Ended September 30, 2020
In millions
Electronics & Imaging	$	1	$	5
Nutrition & Biosciences	5		12
Transportation & Industrial	—		21
Safety & Construction	2		24
Non-Core	1		1
Corporate	5		77
Total	$	14	$	140


2020 Restructuring Program	Severance and Related Benefit Costs		Asset Related Charges		Total
In millions
Year-to-date restructuring charges	$	112	$	28	$	140
Charges against the reserve	—		(28)		(28)
Cash payments	(42)		—		(42)
Reserve balance at September 30, 2020	$	70	$	—	$	70

At September 30, 2020, total liabilities related to the 2020 Restructuring Program were $70 million, recognized in "Accrued and other current liabilities" in the interim Condensed Consolidated Balance Sheets. The Company expects actions related to this program to be substantially complete by the end of 2020.

During the second quarter of 2019 and in connection with the ongoing integration activities, DuPont approved restructuring actions to simplify and optimize certain organizational structures following the completion of the DWDP Distributions (the "2019 Restructuring Program"). The Company has recorded pre-tax restructuring charges of $140 million inception-to-date, consisting of severance and related benefit costs of $106 million and asset related charges of $34 million.

There were no charges incurred related to the 2019 Restructuring Program for the three months ended September 30, 2020. The following table summarizes the charges incurred for the three months ended September 30, 2019 and the nine months ended September 30, 2020 and September 30, 2019:


	Three Months Ended September 30,		Nine Months Ended September 30,
In millions	2019		2020		2019
Severance and related benefit costs	$	48	$	2	$	98
Asset related charges	21		—		24
Total restructuring and asset related charges - net	$	69	$	2	$	122


2019 Restructuring Program Charges (Credits) by Segment	Three Months Ended September 30,		Nine Months Ended September 30,
In millions	2019		2020		2019
Electronics & Imaging	$	35	$	(3)	$	42
Nutrition & Biosciences	4		(3)		18
Transportation & Industrial	6		(7)		18
Safety & Construction	3		(14)		20
Non-Core	3		—		3
Corporate	18		29		21
Total	$	69	$	2	$	122


2019 Restructuring Program	Severance and Related Benefit Costs
In millions
Reserve balance at December 31, 2019	$	86
Year-to-date restructuring charges	2
Non-cash compensation	(6)
Cash payments	(55)
Reserve balance at September 30, 2020	$	27

At September 30, 2020, total liabilities related to the 2019 Restructuring Program were $27 million, recognized in "Accrued and other current liabilities" ($86 million at December 31, 2019) in the interim Condensed Consolidated Balance Sheets. The 2019 Restructuring Program was considered substantially complete at June 30, 2020.

In September and November 2017, the Company approved post-merger restructuring actions under the DowDuPont Cost Synergy Program, which was designed to integrate and optimize the organization following the DWDP Merger and in preparation for the DWDP Distributions. The portions of the charges, costs and expenses attributable to integration and optimization within the Agriculture and Materials Science Divisions are reflected in discontinued operations. The Company has recorded pre-tax restructuring charges attributable to the continuing operations of DuPont of $489 million inception-to-date, consisting of severance and related benefit costs of $213 million, asset related charges of $209 million and contract termination and other charges of $67 million.

There were no charges incurred related to the DowDuPont Cost Synergy Program for the three months ended September 30, 2020. The following table summarizes the charges incurred for the three months ended September 30, 2019 and the nine months ended September 30, 2020 and September 30, 2019:


	Three Months Ended September 30,		Nine Months Ended September 30,
In millions	2019		2020		2019
Severance and related benefit costs (credits)	$	—	$	(2)	$	49
Contract termination and other charges	—		6		16
Asset related charges	14		—		43
Total restructuring and asset related charges - net 1	$	14	$	4	$	108

1. The charge for the three and nine months ended September 30, 2019 includes $13 million and $105 million which was recognized in "Restructuring and asset related charges - net" and $1 million and $3 million which was recognized in "Equity in earnings of nonconsolidated affiliates" in the interim Consolidated Statements of Operations.


DowDuPont Cost Synergy Program Charges (Credits) by Segment	Three Months Ended September 30,		Nine Months Ended September 30,
In millions	2019		2020		2019
Electronics & Imaging	$	—	$	—	$	—
Nutrition & Biosciences	3		—		38
Transportation & Industrial	—		1		—
Safety & Construction	2		5		7
Non-Core	(1)		—		(1)
Corporate	10		(2)		64
Total	$	14	$	4	$	108


DowDuPont Cost Synergy Program	Severance and Related Benefit Costs		Contract Termination Charges		Total
In millions
Reserve balance at December 31, 2019	$	74	$	2	$	76
Year-to-date restructuring (credits) charges	(2)		6		4
Charges against the reserve	—		(1)		(1)
Cash payments	(47)		(2)		(49)
Reserve balance at September 30, 2020	$	25	$	5	$	30

At September 30, 2020, total liabilities related to the DowDuPont Cost Synergy Program were $30 million, recognized in "Accrued and other current liabilities" ($76 million at December 31, 2019) in the interim Condensed Consolidated Balance Sheets. The DowDuPont Cost Synergy Program was considered substantially complete at June 30, 2020.

In the third quarter of 2020, the TCS/HSC Disposal within the Non-Core segment, as well as further softening conditions in the aerospace markets, gave rise to fair value indicators and, thus, served as triggering events requiring the Company to perform a recoverability assessment related to asset groups within its Photovoltaic and Advanced Materials (“PVAM”) business unit. The Company first performed a long-lived asset impairment test and determined that, based on undiscounted cash flows, the carrying amount of certain long-lived assets was not recoverable. Accordingly, the Company estimated the fair value of these assets using both an income approach and a market approach utilizing Level 3 unobservable inputs. As a result, the Company recognized a pre-tax impairment charge of $318 million ($242 million net of tax) recorded within “Restructuring and asset

related charges - net” in the interim Consolidated Statements of Operations for the three and nine months ended September 30, 2020 with the charge impacting definite-lived intangible assets and property, plant, and equipment. See Note 11 for further discussion of goodwill impairment charges recorded during the third quarter of 2020 resulting from the above triggering events.

Additionally, the Company recorded a pre-tax asset impairment charge of $52 million ($39 million net of tax) in the third quarter of 2020 related to indefinite-lived intangible assets within the Non-Core segment which were deemed no longer recoverable as a result of the Non-Core Held for Sale Disposal Groups classification (refer to Note 3 for additional information). The charge was recorded within “Restructuring and asset related charges – net” in the interim Consolidated Statements of Operations for the three and nine months ended September 30, 2020.

In the second quarter of 2020, the Company recorded a pre-tax impairment charge of $21 million ($16 million net of tax) related to indefinite-lived intangible assets within the Transportation & Industrial segment. This charge was recorded within “Restructuring and asset related charges - net” in the interim Consolidated Statements of Operations for the nine months ended September 30, 2020. See Note 11 for further discussion.

In the first quarter of 2020, expectations of proceeds related to certain potential divestitures within the Non-Core segment gave rise to fair value indicators and, thus, triggering events requiring the Company to perform a recoverability assessment related to its biomaterials business unit. The Company performed a long-lived asset impairment test and determined that, based on undiscounted cash flows, the carrying amount of certain long-lived assets was not recoverable. Accordingly, the Company estimated the fair value of these assets using a market approach utilizing Level 3 unobservable inputs. As a result, the Company recognized a pre-tax impairment charge of $270 million ($206 million net of tax) recorded within “Restructuring and asset related charges - net” in the interim Consolidated Statements of Operations for the nine months ended September 30, 2020 with the charge impacting definite-lived intangible assets and property, plant, and equipment.